| Date | Title | Description | Source |
| 23.04.2024 | New report presents good figures from the Swiss biotech sect... |
The overall picture of the Swiss biotech industry in the Swiss Biotech Report published today is qu... | startuptic... |
| 01.04.2024 | Впервые в мире почку свиньи изменили генетически и пересадил... | Хирурги из США провели человеку трансплантацию почки, полученной из генетически модифицированной сви... | incrussia.... |
| 13.03.2024 | CRISPR Therapeutics Proposes New Appointment to the Board of... | - | globenewsw... |
| 12.03.2024 | MaxCyte Reports Fourth Quarter and Full Year 2023 Financial ... | ROCKVILLE, Md., March 12, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leadi... | einpresswi... |
| 08.03.2024 | CRISPR Technology Takes Center Stage at SXSW 2024 for the Fi... | - | globenewsw... |
| 05.03.2024 | Business wind down and take off for listed Swiss startups |
Since its inception in 2012, ObsEva SA (SIX: OBSN) has focused on the development of novel therapie... | startuptic... |
| 13.02.2024 | CRISPR Therapeutics Announces $280 Million Registered Direct... | - | globenewsw... |
| 30.12.2023 | CRISPR в генотерапии. История и право... | Рис.1| Здесь изображена эндонуклеаза Cas9 за работой.Введение
CRISPR – это революционная технология ... | habr.com/r... |
| 05.12.2023 | Carmot’s chance of beating the odds in the biotech market ju... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 17.11.2023 | Green light for world’s first CRISPR gene-edited therapy | | startuptic... |
| 28.03.2023 | Up to $230 million for CRISPR Therapeutics | | startuptic... |
| 16.01.2023 | Какие технологии нужны ЕС? ТОП-10 технологических сфер для с... | Чтобы быть конкурентоспособной, Европе нужно укреплять свои позиции на рынке технологий. Мы составил... | vc.ru/migr... |
| 25.09.2022 | Крипта идёт в безумные стартапы, AI конструирует белки. Техд... | Отдел новостей 25 сентября 2022, 11:23 Крипта идёт в безумные стартапы, AI конструирует белки. Техда... | dev.by/new... |
| 11.01.2022 | CRISPR Therapeutics : Corporate Presentation | ®
Creating transformative gene-based medicines for serious diseases
Corporate Overview | Q4 2021
For... | marketscre... |
| 23.11.2021 | CRISPR Therapeutics : Corporate Presentation | ®
Creating transformative gene-based medicines for serious diseases
Corporate Overview | Q4 2021
For... | marketscre... |
| 08.11.2021 | CRISPR Therapeutics Corporate Presentation | ®
Creating transformative gene-based medicines for serious diseases
Corporate Overview | Q4 2021
For... | marketscre... |
| 10.08.2021 | Bringing immuno-oncology cell therapies to the masses – are ... | | ucltf.co.u... |
| 17.06.2021 | Two Biotech Companies Team Up to Take On Rare Diseases with ... | Thousand Oaks-based startup Capsida Biotherapeutics launched in April with the goal of treating deva... | dot.la/cri... |
| 17.06.2021 | Capsida Partners With CRISPR Therapeutics To Treat ALS and F... | Thousand Oaks-based startup Capsida Biotherapeutics launched in April with the goal of treating deva... | dot.la/cri... |
| 07.03.2021 | "The Code Breaker": Jennifer Doudna and how CRISPR... | When Jennifer Doudna won the Nobel Prize for Chemistry last year, there was no black-tie ceremony in... | cbsnews.co... |
| 29.12.2020 | Grants for companies fighting HIV, neurodegenerative disease... | | startuptic... |
| 29.12.2020 | Grants for companies fighting HIV, neurodegenerative disease... | CRISPR Therapeutics received a grant from the Bill & Melinda Gates Foundation to research in viv... | startuptic... |
| 16.12.2020 | Out of CRISPR pioneer David Liu's lab comes a small mole... | David Liu may be best known as a CRISPR trailblazer behind Editas Medicine, Beam Therapeut... | endpts.com... |
| 07.10.2020 | ‘A terrific choice’: George Church salutes fellow CRISPR pio... | George Church, who is in the thick of both the science and the business of editing genomes with the ... | statnews.c... |
| 30.09.2019 | CRISPR pioneer Feng Zhang's upstart biotech seeks $100M-p... | The CRISPR pioneers’ new, gentler-touch company is aiming for a $100 million initial public... | endpts.com... |
| 31.05.2018 | CRISPR clinical trial hits regulatory speedbump | The companies said they expected to obtain additional information on the FDA’s questions in the near... | medcitynew... |
| 14.05.2018 | Feng Zhang and David Liu's base-editing CRISPR startup offic... | Feng Zhang's latest CRISPR company, Beam Therapeutics, officially came out of stealth Monday with $8... | fiercebiot... |
| 10.05.2018 | Should You Be Using CRISPR for Your Ag Business? | *Updated reference to Pairwise with correction regarding agreement with Monsanto*
Editor’s Note: Von... | agfunderne... |
| 12.04.2018 | A giant gorilla and a winged wolf: Does ‘Rampage’ get the sc... | We here at STAT cover CRISPR a lot. But it’s not every day we get to cover Dwayne “The Rock” Johnson... | statnews.c... |
| 02.10.2017 | Sam Kulkarni takes the helm at CRISPR Therapeutics as fo... | After steering CRISPR Therapeutics to an IPO last year as the last of the big three gene editi... | endpts.com... |
| 22.08.2017 | Building up its I/O ops, CRISPR Therapeutics allies wit... | Marcela V. Maus
CRISPR Therapeutics $CRSP is allying with some top immuno-oncology resear... | endpts.com... |
| 19.06.2017 | China sides with Emmanulle Charpentier and Jennifer Doudna i... | Continuing the patent dispute internationally, China has now given the Charpentier/Doudna side a pat... | techcrunch... |
| 17.04.2017 | CRISPR Therapeutics, Casebia ink AAV deal with StrideBi... | → CRISPR Therapeutics $CRSP and Casebia Therapeutics, a joint-venture established by CRIS... | endpts.com... |
| 03.01.2017 | Versant’s new $400M fund will be early-stage, global and app... | Fund VI adds to the very healthy pool of private investment dollars currently available to healthcar... | medcitynew... |
| 07.12.2016 | Kendall Square’s boarding school for biotechs | Mass Innovation Labs was late to the game, opening in May 2015. But it is clearly doing something di... | medcitynew... |
| 19.10.2016 | Crispr Therapeutics Raises $56M for IPO | BASEL, Switzerland and CAMBRIDGE, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) — CRISPR Therapeutics AG (Na... | citybizlis... |
| 19.10.2016 | Crispr Therapeutics Announces Pricing of Initial Public Offe... | Crispr Therapeutics AG (Nasdaq:CRSP), a Cambridge, MA-based biopharmaceutical company focused on tra... | finsmes.co... |
| 18.10.2016 | CRISPR Therapeutics Announces Pricing of Initial Public Offe... | | startuptic... |
| 21.09.2016 | CRISPR Therapeutics files for $90M IPO | | startuptic... |
| 19.09.2016 | How Bayer Stands to Reinvent GMO with CRISPR and Monsanto Ac... | Editor’s Note: Emma Cowan has been working in agriculture all her life after growing up on her famil... | agfunderne... |
| 09.09.2016 | Gene editing star CRISPR Therapeutics files for $90M IPO... | Emmanuelle Charpentier. Credit: Bianca Fioretti, Hallbauer & Fioretti
In one of the mos... | endpts.com... |
| 09.09.2016 | Gene editing startup CRISPR Therapeutics registers for $90M ... | The lead applications of its technology target beta thalassemia, sickle cell disease. These diseases... | medcitynew... |
| 27.06.2016 | CRISPR Therapeutics Raises Additional $38M | | startuptic... |
| 26.06.2016 | New Leaf Venture Partners Joins $38M Series B for Crispr The... | BASEL, Switzerland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CRISPR Therapeutics, a biopharmaceutical... | citybizlis... |
| 25.06.2016 | Crispr Therapeutics Raises $38M Series B | BASEL, Switzerland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CRISPR Therapeutics, a biopharmaceutical... | citybizlis... |
| 24.06.2016 | Gene-Editing Company Crispr Therapeutics Raises $38M in Seri... | Crispr Therapeutics, a Basel, Switzerland-based gene-editing company, raised an additional $38m in t... | finsmes.co... |
| 24.06.2016 | CRISPR Therapeutics adds $38M to Series B pot, but lags behi... | CRISPR Therapeutics has raised an additional $38 million as part of its Series B raise, bringing its... | fiercebiot... |
| 12.05.2016 | After rivals’ IPOs, will CRISPR Therapeutics go public or st... | It has a license to one of the biggest scientific advances in history, and its rivals have made big ... | statnews.c... |
| 19.01.2016 | Accidental snake oil: How healthcare media can hurt people | This is hugely important as biotechnology, in particular, hurtles to the forefront of the media – wi... | medcitynew... |
| 21.12.2015 | Bayer is investing USD 335 million in an alliance with CRISP... | | startuptic... |
| 26.10.2015 | Vertex closes $105M CRISPR gene editing deal | The companies explore how to use CRISPR/Cas9 technology to correct the genetic aberrations found in ... | medcitynew... |
| 11.08.2015 | CRISPR: Editas’ $120M proves it isn’t a bunch of hype. Here ... | But that’s already turned quickly on its head.
Confidence is growing in the technology, as evidenced... | medcitynew... |
| 23.06.2015 | Five conspicuous omissions from MIT Tech Review’s 50 smartes... | …we did not have trouble finding big ideas. To make the list, a company must have truly innovative t... | medcitynew... |
| 13.05.2015 | The Genome Engineering Revolution | Ryan Clarke Contributor
More posts by this contributor
A Third Act For Biofuels
James Hyun Contribut... | techcrunch... |
| 30.04.2015 | CRISPR Therapeutics Raises Additional $64 Million | | startuptic... |
| 29.04.2015 | Crispr Therapeutics Raises $64m in Series A and Series B Ven... | Crispr* Therapeutics, a Basel, Switzerland-based biopharmaceutical company focused on translating CR... | finsmes.co... |
| 28.04.2014 | CRISPR Therapeutics raises $25 million in Series A financing | | startuptic... |
| 24.04.2014 | Crispr Therapeutics Raises $25M in Series A Funding | Crispr Therapeutics, a Basel, Switzerland-based biopharmaceutical company that focuses on the gene-e... | finsmes.co... |
| 24.04.2014 | CRISPR Therapeutics Raises $25M in Series A |
BASEL, SWITZERLAND, Biopharmaceutical company focused on the breakthrough gene-editing technology ... | vcnewsdail... |
| - | CRISPR: Editas’ $120M proves it isn’t a bunch of hype. Here ... | CRISPR/Cas9 gene editing has zoomed to the forefront of the biotech investment scape in the past yea... | medcitynew... |
| - | CRISPR clinical trial hits regulatory speedbump | Regulators hit the brakes on a gene-editing therapy train before it even left the station.
CRISPR Th... | medcitynew... |
| - | Five conspicuous omissions from MIT Tech Review’s 50 smartes... | We know who made the cut in the latest MIT Technology Review list of the 50 Smartest Companies of 20... | medcitynew... |
| - | Kendall Square’s boarding school for biotechs | A communal area at the Mass Innovation Labs facility
It’s hard to get excited about a biotech shared... | medcitynew... |
| - | Versant’s new $400M fund will be early-stage, global and app... | Brad Bolzon, managing director of Versant Ventures
It’s a new year and a new pot of cash for Versant... | medcitynew... |
| - | Vertex closes $105M CRISPR gene editing deal | Vertex Pharmaceuticals is getting in on the gene editing game, teaming up with CRISPR Therapeutics i... | medcitynew... |
| - | Gene editing startup CRISPR Therapeutics registers for $90M ... | Gene editing business CRISPR Therapeutics has registered for an initial public offering seeking to r... | medcitynew... |
| - | Accidental snake oil: How healthcare media can hurt people | Be careful with your words.
A new podcast from Health News Review points out the dangers of spitting... | medcitynew... |
